SGO on the GO The Society of Gynecologic Oncology

This is the first of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. After going over some general information on Trastuzumab Deruxtecan ENHERTU® including when to use the drug, checking patient performance status, toxicity, response rates in breast, and line of therapy and treatment option. The multidisciplinary panel will discuss dosing and drug preparation for giving Trastuzumab Deruxtecan ENHERTU®. The session wraps up with some key take home ...

This is the second of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trastuzumab Deruxtecan ENHERTU®. Focusing on dosing, breast scoring, HER2, infusion reactions, lab examinations, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.2023-2024 SGO ...

This is the last of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trastuzumab Deruxtecan ENHERTU®. When to dose adjust and hold or even discontinue Trastuzumab Deruxtecan ENHERTU®. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trastuzumab Deruxtecan ENHERTU®. 2023-2024 SGO Chemotherapy and Targeted ...

In this podcast, we will focus on same day discharge as part of Enhanced Recovery after Surgery (ERAS).Over the past two decades, and especially after the publication of the GOG LAP2 trial, minimally invasive surgery has been widely adopted in gynecologic oncology, as it is associated with lower rates of complications, and improved postoperative recovery and return to normal activity. Postoperative hospitalization is typically shorter after minimally invasive (MIS) hysterectomy, and many...

This episode is part 2 of the Immunotherapy Series, which reviews common controversies affecting daily use of immune checkpoint inhibitors (ICIs) in the clinic, such as treatment options for immune related adverse effects beyond corticosteroids, re-challenging after toxicity, use of ICIs in patients with auto-immune conditions, and drug interactions. Moderator:Karin K. Shih, MDGynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/NorthwellSpeakers:Erin Zachol...

This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing. Moderator:Karin K. Shih, MDGynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/NorthwellSpeakers:Erin Zacholski, PharmD, BCOPAssistant Professor - VCU School of PharmacyClinical P...